Bristol Myers Squibb (CELG-RI) Cash from Operations (2009 - 2026)

Bristol Myers Squibb has disclosed Cash from Operations across 18 years of filings, most recently posting 1104000000.0 for Q1 2026.

• In Q1 2026, Cash from Operations fell 43.5% year-over-year to 1104000000.0; the TTM figure through Mar 2026 stood at 13306000000.0 (down 7.02% YoY), while the FY2025 annual figure was 14156000000.0, down 6.81% from the prior year.
• Cash from Operations declined to 1104000000.0 in Q1 2026, from 1974000000.0 in the prior quarter.
• Over the last five years, Cash from Operations for CELG-RI reached as high as 6311000000.0 in Q3 2025 and fell as low as 1104000000.0 in Q1 2026.
• The 5-year median for Cash from Operations is 3306000000.0 (2022), against an average of 3375058823.53.
• The widest YoY moves for Cash from Operations: up 68.4% in 2025, down 55.53% in 2025.
• A 5-year view of Cash from Operations shows it stood at 3306000000.0 in 2022, then climbed by 28.61% to 4252000000.0 in 2023, then gained by 4.4% to 4439000000.0 in 2024, then slumped by 55.53% to 1974000000.0 in 2025, then slumped by 44.07% to 1104000000.0 in 2026.
• According to Business Quant data, Cash from Operations over the past three periods registered 1104000000.0, 1974000000.0, and 6311000000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.